Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Lapointe

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Annals of Palliative Medicine|March 23, 2026
Driving safety in patients with primary brain tumours and brain metastases in Canada: a scoping reviewKevin Nishimura, Jennifer Yao, Sarah Lapointe, et al.
Journal of Neuropathology and Experimental Neurology|February 4, 2026
Gliomas with succinate dehydrogenase deficiency: A case series and brief review of the literature of oncometabolite-driven gliomagenesisMadison T Gray, Romain Cayrol, Adriana May, et al.
Journal of Affective Disorders|July 29, 2025
Measuring long-term psychiatric outcomes in post-acute autoimmune encephalitisJulien Hébert, Ramy Gabarin, Sydney Lee, et al.
Current Oncology (Toronto, Ont.)|September 26, 2025
A Retrospective Study on Prognostic Factors and Systemic Treatments of Refractory MeningiomasDan-Thanh Christine Nguyen, Cyril Nader, Karl Bélanger, et al.
Frontiers in Oncology|October 17, 2022
Molecular testing for adolescent and young adult central nervous system tumors: A Canadian guidelineMary Jane Lim-Fat, Maria Macdonald, Sarah Lapointe, et al.
Current Oncology (Toronto, Ont.)|April 25, 2025
Canadian Expert Consensus Recommendations for the Diagnosis and Management of Glioblastoma: Results of a Delphi StudyWarren P Mason, Rebecca A Harrison, Sarah Lapointe, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 5, 2024
Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in AdultsChristopher Hahn, Adrian Budhram, Katayoun Alikhani, et al.
Neuro-Oncology Advances|December 23, 2020
Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adultsJessica D Schulte, Robin A Buerki, Sarah Lapointe, et al.
Current Oncology (Toronto, Ont.)|July 26, 2024
Canadian Consensus for Treatment of BRAF <i>V600E</i> Mutated Pediatric and AYA GliomasCraig Erker, Magimairajan Issai Vanan, Valérie Larouche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2026
Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-mutant: An International Multi-Institutional StudyCameron Crowell, Nikhil P Mankuzhy, Julie Bennett, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Annals of Palliative Medicine|March 23, 2026
Driving safety in patients with primary brain tumours and brain metastases in Canada: a scoping reviewKevin Nishimura, Jennifer Yao, Sarah Lapointe, et al.
Journal of Neuropathology and Experimental Neurology|February 4, 2026
Gliomas with succinate dehydrogenase deficiency: A case series and brief review of the literature of oncometabolite-driven gliomagenesisMadison T Gray, Romain Cayrol, Adriana May, et al.
Journal of Affective Disorders|July 29, 2025
Measuring long-term psychiatric outcomes in post-acute autoimmune encephalitisJulien Hébert, Ramy Gabarin, Sydney Lee, et al.
Current Oncology (Toronto, Ont.)|September 26, 2025
A Retrospective Study on Prognostic Factors and Systemic Treatments of Refractory MeningiomasDan-Thanh Christine Nguyen, Cyril Nader, Karl Bélanger, et al.
Frontiers in Oncology|October 17, 2022
Molecular testing for adolescent and young adult central nervous system tumors: A Canadian guidelineMary Jane Lim-Fat, Maria Macdonald, Sarah Lapointe, et al.
Current Oncology (Toronto, Ont.)|April 25, 2025
Canadian Expert Consensus Recommendations for the Diagnosis and Management of Glioblastoma: Results of a Delphi StudyWarren P Mason, Rebecca A Harrison, Sarah Lapointe, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 5, 2024
Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in AdultsChristopher Hahn, Adrian Budhram, Katayoun Alikhani, et al.
Neuro-Oncology Advances|December 23, 2020
Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adultsJessica D Schulte, Robin A Buerki, Sarah Lapointe, et al.
Current Oncology (Toronto, Ont.)|July 26, 2024
Canadian Consensus for Treatment of BRAF <i>V600E</i> Mutated Pediatric and AYA GliomasCraig Erker, Magimairajan Issai Vanan, Valérie Larouche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2026
Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-mutant: An International Multi-Institutional StudyCameron Crowell, Nikhil P Mankuzhy, Julie Bennett, et al.
Pageof 3